Regulatory Harmonisation of Digital Health Applications Across the European Union: A Comparative Policy Study

Authors

  • Matic K Department of Health Policy, University of Zagreb, Zagreb, Croatia Author
  • Nikolaou M Department of Health Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece Author
  • Dvorak M Department of Public Administration, Charles University, Prague, Czech Republic Author

DOI:

https://doi.org/10.5281/zenodo.22661484

Keywords:

digital health regulation, Medical Device Regulation, European Health Data Space, digital therapeutics reimbursement, health technology assessment

Abstract

Background: Digital health applications, including software as a medical device and reimbursable digital therapeutics, are subject
to a layered European Union (EU) regulatory environment in which device-level rules are formally harmonised while
reimbursement and cross-border data governance remain largely national competences. Objective: This review compares the state
of regulatory harmonisation across three domains - device classification and market access under the Medical Device Regulation
(MDR) and the Artificial Intelligence Act, national reimbursement and health technology assessment (HTA) pathways, and
cross-border interoperability under the European Health Data Space (EHDS) - to identify where EU-wide convergence has been
achieved and where fragmentation persists. Methods: A narrative comparative policy review synthesised peer-reviewed literature
identified through targeted searches of PubMed/MEDLINE and Crossref-indexed journals, with each candidate source individually
verified against its publisher or Crossref bibliographic record before inclusion; sources were organised thematically across the three
domains, comparing Germany's DiGA pathway, France's PECAN scheme, Belgium's mHealthBELGIUM validation pyramid, and the
United Kingdom's NICE Evidence Standards Framework. Findings: The MDR provides substantial, directly applicable harmonisation
of device classification and CE marking, though notified body capacity constraints produce uneven implementation across member
states; the emerging AI Act adds a further, only partially reconciled conformity layer for AI-enabled products. Reimbursement
remains the least harmonised domain, with Germany, France, Belgium, and the United Kingdom each applying structurally distinct
evidentiary and financing models despite shared underlying MDR classification. The EHDS represents an ambitious attempt to
harmonise cross-border data interoperability, but its legal ambition currently outpaces the technical and institutional readiness of
privacy-enhancing technologies and federated data infrastructure across member states. Conclusions: EU harmonisation of digital
health applications is progressing unevenly across three largely independent axes - device classification, reimbursement, and data
interoperability - each requiring distinct policy benchmarks and further investment in implementation capacity rather than legal
text alone.

References

Schmidt L, Pawlitzki M, Renard BY, Meuth SG, Masanneck L (2024) The three-year evolution of Germany's Digital Therapeutics reimbursement program and its path forward. npj Digital Medicine, 7(1):139, DOI:10.1038/s41746-024-01137-1.

Mäder M, Timpel P, Schönfelder T, Militzer-Horstmann C, Scheibe S, Heinrich R, Häckl D (2023) Evidence requirements of permanently listed digital health applications (DiGA) and their implementation in the German DiGA directory: an analysis. BMC Health Services Research, 23(1):369, DOI:10.1186/s12913-023-09287-w. Illustrative comparative maturity of regulatory harmonisation across three domains of EU digital health governance: device classification and market access, national reimbursement/HTA, and cross-border data interoperability, synthesized from the comparative legal and policy literature reviewed (Francesconi et al., 2025; Tarricone et al., 2024; Hussein et al., 2025).

Lievevrouw E, Marelli L, Van Hoyweghen I (2024) Weaving EU digital health policy into national healthcare practices. The making of a reimbursement standard for digital health technologies in Belgium. Social Science & Medicine, 346:116620, DOI:10.1016/j.socscimed.2024.116620.

Unsworth H, Dillon B, Collinson L, Powell H, Salmon M, Oladapo T, Ayiku L, Shield G, Holden J, Patel N, Campbell M, Greaves F, Joshi I, Powell J, Tonnel A (2021) The NICE Evidence Standards Framework for digital health and care technologies - Developing and maintaining an innovative evidence framework with global impact. DIGITAL HEALTH, 7:20552076211018617, DOI:10.1177/20552076211018617.

Francesconi M, Cangi M, Tamarri S, Conditi N, Menicucci C, Ravizza A, Cattaneo L, Bianchini E (2025) Navigating regulatory challenges across the life cycle of a SaMD. Journal of Biomedical Informatics, 167:104856, DOI:10.1016/j.jbi.2025.104856.

Svempe L (2026) Impact of the new European medical device regulation on digital health manufacturers. npj Digital Medicine, 9(1):638, DOI:10.1038/s41746-026-02812-1.

Tarricone R, Petracca F, Weller HM (2024) Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning. npj Digital Medicine, 7(1):268, DOI:10.1038/s41746-024-01263-w.

Arcà E, Heldt D, Smith M (2025) Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France. DIGITAL HEALTH, 11:20552076241308704, DOI:10.1177/20552076241308704.

Hussein R, Gyrard A, Abedian S, Gribbon P, Alabart Martinez S (2025) Interoperability Framework of the European Health Data Space for the Secondary Use of Data: Interactive European Interoperability Framework-Based Standards Compliance Toolkit for AI-Driven Projects. Journal of Medical Internet Research, 27:e69813, DOI:10.2196/69813.

van Drumpt S, Chawla K, Barbereau T, Spagnuelo D, van de Burgwal L (2025) Secondary use under the European Health Data Space: setting the scene and towards a research agenda on privacy-enhancing technologies. Frontiers in Digital Health, 7:1602101, DOI:10.3389/fdgth.2025.1602101.

Carradinha M, Mendes VIS, Moura RP, Silva NP, Rocha L, Gonçalves J, Antunes I, Schiza E, Pattichis CS, Zanini A, Pajić V, Pinto CS (2026) Telemedicine and the European Health Data Space: a new paradigm for healthcare in the EU. Frontiers in Digital Health, 7:1713758, DOI:10.3389/fdgth.2025.1713758.

Vukovic J, Ivankovic D, Habl C, Dimnjakovic J (2022) Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective. Archives of Public Health, 80(1):115, DOI:10.1186/s13690-022-00866-7.

Aboy M, Minssen T, Vayena E (2024) Navigating the EU AI Act: implications for regulated digital medical products. npj Digital Medicine, 7(1):237, DOI:10.1038/s41746-024-01232-3.

Schmidt J, Schutte NM, Buttigieg S, Novillo-Ortiz D, Sutherland E, Anderson M, de Witte B, Peolsson M, Unim B, Pavlova M, Stern AD, Mossialos E, van Kessel R (2024) Mapping the regulatory landscape for artificial intelligence in health within the European Union. npj Digital Medicine, 7(1):229, DOI:10.1038/s41746-024-01221-6.

Sippli K, Deckert S, Schmitt J, Scheibe M (2025) Healthcare effects and evidence robustness of reimbursable digital health applications in Germany: a systematic review. npj Digital Medicine, 8(1):495, DOI:10.1038/s41746-025-01879-6.

Liang J, Fang Q, Jiao X, Xiang P, Ma J, Zhang Z, Liu Y, He Y, Li Y, He Z, Lei J (2025) Approved trends and product characteristics of digital therapeutics in four countries. npj Digital Medicine, 8(1):308, DOI:10.1038/s41746-025-01660-9.

Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, Winders T, van Vugt J (2024) Adoption of Digital Therapeutics in Europe. Therapeutics and Clinical Risk Management, 20:939-954, DOI:10.2147/TCRM.S489873.

Phuyal S, Bhandari M, Correia Bezerra R, Bista R, Ferreira JC (2026) Dynamic Consent for Secondary Use of Health Data: Challenges and Opportunities Under European Law. JMIR Medical Informatics, 14(1):e93348, DOI:10.2196/93348.

Lalova-Spinks T, Valcke P, Ioannidis JPA, Huys I (2024) EU-US data transfers: an enduring challenge for health research collaborations. npj Digital Medicine, 7(1):215, DOI:10.1038/s41746-024-01205-6.

Downloads

Published

2026-06-16